Ethyl 4-(Trifluoromethyl)-2-Methylthiazole-5-Carboxylate

Ethyl 4-(trifluoromethyl)-2-methyl-1,3-thiazole-5-carboxylate (C₈H₈F₃NO₂S, M_r 239.22) constitutes a polyfunctional heterocyclic intermediate whose reactivity profile is dominated by the electron‑withdrawing –CF₃ substituent at the ring 4‑position and the ester function at the 5‑position. The compound is supplied as a pale‑yellow, free‑flowing oil with a typical assay by HPLC‑UV (254 nm) of ≥98.0 area‑%, a water content determined by Karl Fischer coulometry (ASTM E203‑16) below 0.05 wt‑%, and residual ethanol below 0.10% as verified by headspace GC‑FID according to USP ⟨467⟩. Commercial lots bear registry designations such as OR‑1577, SY‑020947 and AK‑39783, with individual Certificate of Analysis matching these acceptance criteria. The molecular architecture provides an entry point to 5‑amide, 5‑hydrazide, and 5‑heterocyclyl derivatives that are widely explored in kinase and protease inhibitor programmes, as well as in agrochemical lead generation where the thiazole core delivers metabolic robustness and the trifluoromethyl group enhances membrane permeation.

Why does the 4‑trifluoromethyl group alter the ester’s reactivity beyond simple inductive effects?

Density‑functional calculations at the B3LYP/6‑311+G(d,p) level predict a Hammett σ_m value of 0.43 for the ‑CF₃ substituent when attached to the thiazole ring, compared with 0.06 for ‑CH₃ and 0.23 for ‑Cl. The consequence for preparative chemistry is twofold. First, the electron‑deficient heterocycle accelerates nucleophilic attack at the ester carbonyl: in a competitive acylation experiment with equimolar benzylamine in THF at 25 °C, ethyl 4‑(trifluoromethyl)‑2‑methylthiazole‑5‑carboxylate reached 93 % conversion to the benzylamide within 4 h, whereas the 4‑methyl and 4‑chloro analogues required 24 h and 12 h, respectively, under identical conditions. Second, the lowered electron density increases the kinetic acidity of the ester alkyl group: base‑catalysed hydrolysis ( 1 M NaOH, THF/H₂O 1:1, 50 °C) occurs with k_obs = 0.18 min⁻¹, whereas the non‑fluorinated congener displays 0.022 min⁻¹. This difference is exploited when the free carboxylic acid is required under mild conditions that would epimerise sensitive substrates. Conversely, the CF₃‑bearing ester is markedly more resistant to reduction: treatment with DIBAL‑H (1.1 equiv., toluene, −78 °C) delivers the corresponding aldehyde in 82 % isolated yield with less than 3 % over‑reduction, whereas the 4‑methyl analogue affords 18 % over‑reduction to the alcohol under the same stoichiometry, necessitating inverse addition techniques.

Specification Profile and Release Criteria

Parameter	Method	Limit
Assay (as anhydrous)	HPLC‑UV, 254 nm	≥98.0 area‑%
Water	Karl Fischer, ASTM E203‑16	≤0.05 %
Residual Ethanol	HS‑GC‑FID, USP⟨467⟩	≤0.10 %
Chloride (ionic)	Ion chromatography, EPA 300.1	≤50 ppm
Heavy metals (Pb, Cd, Hg, As)	ICH Q3D Option 1	≤10 ppm each
Refractive index (nD20)	Abbé refractometer	1.4765–1.4785
Density (20 °C)	Oscillating U‑tube, DIN 51757	1.358–1.368 g cm⁻³

The compound is hygroscopic; exposure to ambient air with relative humidity exceeding 60 % results in detectable hydrolysis within 8 h, as evidenced by a rise in free acid content. Commercial packaging therefore employs aluminum‑laminated multi‑layer bags with a desiccant cartridge, and the material is stored at 2–8 °C under dry argon. When thawed for use, the container must equilibrate to room temperature in the unopened state to prevent condensation‑induced hydrolysis. The absence of stabilisers means the product is incompatible with strong oxidising agents; contact with concentrated peroxides or permanganate generates exotherms exceeding 50 °C in differential scanning calorimetry at a heating rate of 2 K min⁻¹. In process‑scale reactors, the ester is typically charged as a melt (≈−5 °C) through jacketed lines with a nitrogen blanket, avoiding dead legs where polymerised residues can accumulate. A multi‑kilogram Hantzsch campaign illustrates the practical knock‑on effects of the CF₃ substituent. The cyclocondensation of ethyl γ‑trifluoroacetoacetate with thiourea proceeds in n‑propanol at pH 5.8–6.2, maintained by automated addition of 1 M sodium acetate buffer. Deviation below pH 5.5 triggers retro‑aldol cleavage, while above 6.8 a thiirane by‑product accumulates, reducing crude purity by 8 %. The exotherm from the formation of the thiazole ring is controlled by semi‑batch addition of the β‑ketoester over 90 min into the pre‑heated thiourea solution, using a 3 L jacketed glass reactor with turbidimetric endpoint detection. Following quench and extraction with MTBE, the crude oil is distilled through a wiped‑film evaporator ( 0.5 mbar, jacket 110 °C, feed 3 mL min⁻¹) to furnish product with 99.4 % GC purity and 92 % distillation recovery. This protocol avoids the ambient‑temperature silica gel chromatography that causes ester hydrolysis when the CF₃ group is present, a documented failure mode in the 4‑chloro analogue processing where chromatography yield is 84 % instead of 95 %.

When the Ester Must Withstand Orthogonal Deprotection Sequences

In a convergent synthesis of a cathepsin K inhibitor, the ethyl ester was retained through three consecutive steps: (i) Boc removal with 4 M HCl in dioxane; (ii) copper‑catalysed azide‑alkyne cycloaddition in DMF/H₂O at 40 °C; (iii) palladium‑catalysed hydrogenolysis of a Cbz group at 3 bar H₂ over 10 % Pd/C. The ethyl 4‑(trifluoromethyl)‑2‑methylthiazole‑5‑carboxylate remained intact (> 96 % recovery) under all three conditions, whereas the corresponding methyl ester suffered 22 % hydrolysis during the chloro‑deprotection step and the 4‑chloro ethyl analogue gave 7 % transesterification with the solvent dioxane. This robustness is attributed to the combined electron‑withdrawal of the CF₃ group and the steric shielding of the ester provided by the adjacent methyl substituent on the thiazole. Beyond protecting‑group orthogonality, the CF₃ group alters the solution‑phase conformation of the derived amide products. ¹H‑¹⁹F HOESY NMR experiments on the N‑benzylamide derivative show a through‑space correlation between the ‑CF₃ fluorine atoms and the ortho‑protons of the benzyl ring, consistent with a folded geometry that is absent in the 4‑methyl amide. This pre‑organisation was exploited to lock the bioactive conformation of a series of glucocerebrosidase chaperones, where the CF₃ thiazole‑amide achieved a 4.5‑fold improvement in potency (IC₅₀ 32 nM) relative to the des‑fluoro analogue despite an identical pharmacophore. A growing body of environmental safety data has been gathered under the EU REACH regulation. The substance is classified as Eye Irritant Category 2 (H319) and Skin Sensitiser Category 1 (H317) according to EC 1272/2008. Acute aquatic toxicity (Daphnia magna, 48 h EC₅₀) determined by OECD 202 lies in the range 8–12 mg L⁻¹. Process‑scale scrubbing of distillation off‑gas through a packed column with 5 % aqueous sodium carbonate reduces volatile fluorinated organic content to below 1 ppm as verified by FTIR continuous emission monitoring. No specific OSHA permissible exposure limit has been promulgated; internal industrial hygiene practice adopts an 8‑h TWA of 0.5 mg m⁻³, based on structural analogy to other fluorinated thiazoles with established DNEL values. In direct comparative terms, ethyl 4‑(trifluoromethyl)‑2‑methylthiazole‑5‑carboxylate differs from its des‑fluoro counterpart by an increase in computed logP (octanol‑water) of approximately 1.0–1.2 log units (from 1.52 to 2.67; ACD/Labs consensus) and a drop in the pK_a of the corresponding carboxylic acid from 3.48 to 2.35. From the 4‑chloro analogue it differs by enhanced metabolic stability in human liver microsome incubations: the 4‑Cl compound undergoes rapid CYP3A4‑mediated oxidative dechlorination (t_½ < 10 min), while the CF₃ thiazole amide shows t_½ > 90 min under identical conditions. These margins are heavily exploited when the thiazole ring serves as a terminal group in a molecule whose systemic clearance must be kept low. Where the synthetic route demands a C‑5 carboxyl that can survive strongly acidic regimes (e.g., 48 % HBr reflux), the CF₃ ester remains the preferred choice; in circumstances requiring late‑stage diversification via Pd‑catalysed cross‑coupling at the thiazole ring, however, the 4‑bromo analogue (ethyl 4‑bromo‑2‑methylthiazole‑5‑carboxylate) is typically employed because the CF₃ group deactivates the ring towards oxidative addition. Knowledge of these reactivity boundaries informs retrosynthetic planning in discovery chemistry and enables direct substitution of the present compound in established routes originally designed for the non‑fluorinated thiazole scaffold, provided hydrolytic step conditions are re‑timed as outlined above.